Cited 4 times in
Rescue treatment with intra-arterial tirofiban infusion and emergent carotid stenting
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김동준 | - |
dc.contributor.author | 이경열 | - |
dc.date.accessioned | 2015-05-19T17:07:19Z | - |
dc.date.available | 2015-05-19T17:07:19Z | - |
dc.date.issued | 2008 | - |
dc.identifier.issn | 0513-5796 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/107542 | - |
dc.description.abstract | Rapid arterial rethrombosis is associated with high-grade residual stenosis and usually occurs at the site of the initial occlusion, resulting in reocclusion of the recanalized artery. Platelets may play an active role in such rethrombosis after thrombolytic-induced clot lysis. Given that glycoprotein IIb/IIIa receptor blockers, like tirofiban, prevent thrombus formation by inhibiting the final common pathway of platelet aggregation, they may be helpful for treating rethrombosis after thrombolysis. A 64-year-old man presented with an acute ischemic stroke due to internal carotid artery (ICA) occlusion. The ICA was recanalized by intravenous thrombolysis but reoccluded shortly after recanalization. The reoccluded ICA was successfully recanalized using intra-arterial tirofiban. A carotid stent was subsequently inserted to relieve severe stenosis and to prevent recurrent stroke. Here, we report a case of rescue treatment of a successfully recanalized ICA by intra- arterial tirofiban. We suggest that rescue use of intra-arterial tirofiban may be effective and safe, especially in hemorrhage prone situations, due to the relatively lower dose of tirofiban compared with intravenous doses. | - |
dc.description.statementOfResponsibility | open | - |
dc.format.extent | 857~859 | - |
dc.relation.isPartOf | YONSEI MEDICAL JOURNAL | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Carotid Artery, Internal* | - |
dc.subject.MESH | Carotid Stenosis/diagnostic imaging | - |
dc.subject.MESH | Carotid Stenosis/drug therapy* | - |
dc.subject.MESH | Carotid Stenosis/surgery | - |
dc.subject.MESH | Emergency Treatment | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Infusions, Intra-Arterial | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Radiography | - |
dc.subject.MESH | Stents | - |
dc.subject.MESH | Tirofiban | - |
dc.subject.MESH | Tyrosine/administration & dosage | - |
dc.subject.MESH | Tyrosine/analogs & derivatives* | - |
dc.subject.MESH | Tyrosine/therapeutic use | - |
dc.title | Rescue treatment with intra-arterial tirofiban infusion and emergent carotid stenting | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Neurology (신경과학) | - |
dc.contributor.googleauthor | Tae Jin Song | - |
dc.contributor.googleauthor | Kee Oog Lee | - |
dc.contributor.googleauthor | Dong Joon Kim | - |
dc.contributor.googleauthor | Kyung-Yul Lee | - |
dc.identifier.doi | 10.3349/ymj.2008.49.5.857 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A00410 | - |
dc.contributor.localId | A02648 | - |
dc.relation.journalcode | J02813 | - |
dc.identifier.eissn | 1976-2437 | - |
dc.identifier.pmid | 18972609 | - |
dc.subject.keyword | Carotid stent | - |
dc.subject.keyword | glycoprotein Iib/IIIa receptor blocker | - |
dc.subject.keyword | tissue plasminogen activator | - |
dc.contributor.alternativeName | Kim, Dong Joon | - |
dc.contributor.alternativeName | Lee, Kyung Yul | - |
dc.contributor.affiliatedAuthor | Kim, Dong Joon | - |
dc.contributor.affiliatedAuthor | Lee, Kyung Yul | - |
dc.rights.accessRights | free | - |
dc.citation.volume | 49 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 857 | - |
dc.citation.endPage | 859 | - |
dc.identifier.bibliographicCitation | YONSEI MEDICAL JOURNAL, Vol.49(5) : 857-859, 2008 | - |
dc.identifier.rimsid | 57279 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.